Finance

Anthropic's IPO: A $3.5 Billion Japan Allocation and a $1.5–2 Trillion Valuation Range

Marcus SterlingPublished 15m ago4 min readBased on 13 sources
Reading level
Anthropic's IPO: A $3.5 Billion Japan Allocation and a $1.5–2 Trillion Valuation Range
source:anthropic.com

Anthropic plans to sell $3.5 billion of shares to investors in Japan, according to its IPO filing, as Reuters reported. The filing did not state the overall size of the offering, and the prospectus left out a target valuation. That leaves the Japan tranche, one slice of the deal, as the only concrete allocation figure so far.

The company filed papers to sell shares to the public for the first time, a step the Associated Press reported on October 25. An IPO, or initial public offering, is the first sale of a company's stock to the public. Earlier, in June, Anthropic had confidentially submitted a draft S-1 registration statement to the Securities and Exchange Commission. The public S-1 is the main disclosure document: it carries the risk factors, financial statements and share structure that prospective buyers will price against.

Timing is the next thing to watch. The Wall Street Journal reported that Anthropic is aiming to go public the week of November 16, in an offering that could value the company at between $1.5 trillion and $2 trillion. People familiar with the matter expect the targeted valuation to land within that range. That is roughly two weeks from the latest filing report, so the window for bookbuilding, the process of collecting investor orders to set the price, is short.

The range itself is wide. The $500 billion gap between its floor and ceiling is about a quarter of the top figure. The valuation path has also moved quickly. Anthropic raised $13 billion in a Series F, a private funding round, led by ICONIQ at a $183 billion post-money valuation, meaning the value after the new cash comes in. The company announced that round in September 2025. In February 2026 it raised $30 billion in a Series G led by GIC and Coatue at a $380 billion post-money valuation. The Journal reported in late May that the company had hit a $965 billion valuation, surpassing OpenAI, and that its valuation was expected to reach $1.5 trillion or higher. Anthropic's $65 billion Series H, led by Altimeter Capital, Dragoneer, Greenoaks and Sequoia Capital, was announced days earlier. The low end of the IPO range sits roughly 55 percent above the May figure.

Pricing signals are mixed. Reuters reported on October 26 that some current and prospective investors are valuing the company at about $1.5 trillion, down from roughly $2 trillion a week earlier.

Private marks and IPO targets are not the same instrument, and one investor's valuation is not a clearing price, the level at which the deal actually sells. Still, the recent movement sits at the bottom of the published range, not the middle. For a public buyer, the gap between $1.5 trillion and $2 trillion is a third of the lower price. That is the kind of gap that decides whether a stock looks priced for growth or for a discount.

Investors have also pressed the company on specific risks. In August, the Journal reported that they raised questions about cheaper Chinese AI systems, tensions with the Trump administration and opposition to data centers.

These are not new concerns. They are, however, the ones a roadshow, the company's pitch to large investors, will have to answer. They bear directly on the revenue and capital spending assumptions behind any valuation multiple, which is the ratio of a company's price to its earnings or sales.

The competition for capital runs alongside. Reuters reported on October 20 that OpenAI is seeking to accelerate its own fundraising ahead of Anthropic's IPO. Two frontier-model developers drawing on the same pool of large institutional money in the same quarter could tighten the order book for both. Alternatively, the market could widen if the buyer base grows.

For ordinary savers, the practical question is less the headline number than access and price. The $3.5 billion Japan tranche is one allocation, and the filing did not give the overall size, so the share available to any given group is unclear. Retail investors buying on the first day of trading would pay whatever the book clears at, which could sit anywhere in the range reported so far.

Nothing here is a view on whether that price is attractive. It is a reminder that the valuation most people will see is the one set in a few days of bookbuilding, not the one in the press.